Liu, Cailian
Memorial Sloan Kettering Cancer Center
4 papers on CoChat
Most cited papers
- Verified
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 4,286
- Verified
Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
Hellmann, M. D., Nathanson, T., Rizvi, H., Creelan, B. C., Sanchez-Vega, F., Ahuja, A., Ni, A., Novik, J. B., Mangarin, L. M. B., Abu-Akeel, M., et al. (2018) · Cancer Cell
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 1,095
- Verified
Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
Postow, M. A., Manuel, M., Wong, P., Yuan, J., Dong, Z., Liu, C., Perez, S., Tanneau, I., Noel, M., Courtier, A., et al. (2015) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 232
- Verified
Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity
Zappasodi, R., Budhu, S., Hellmann, M. D., Postow, M. A., Senbabaoglu, Y., Manne, S., Gasmi, B., Liu, C., Zhong, H., Li, Y., et al. (2018) · Cancer Cell
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 142
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free